These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14587695)

  • 1. Article by A Jain: Does homeopathy reduce the cost of conventional drug prescribing?
    Ernst E
    Homeopathy; 2003 Oct; 92(4):233; author reply 233. PubMed ID: 14587695
    [No Abstract]   [Full Text] [Related]  

  • 2. Does homeopathy reduce the cost of conventional drug prescribing? A study of comparative prescribing costs in general practice.
    Jain A
    Homeopathy; 2003 Apr; 92(2):71-6. PubMed ID: 12725248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational prescribing in patients with arterial hypertension].
    Torres Pacho JA; Mora Guío FJ; Charques Velasco E; Alonso Martínez MM
    Gac Sanit; 2002; 16(2):196-7; author reply 197. PubMed ID: 11958758
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving cost-effectiveness of hypertension management at a community health centre.
    Edwards PR; Lunt DW; Fehrsen GS; Lombard CJ; Steyn K
    S Afr Med J; 1998 May; 88(5):549-54. PubMed ID: 9638122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an evidence-based repertory: clinical evaluation of Veratrum album.
    Van Wassenhoven M
    Homeopathy; 2004 Apr; 93(2):71-7. PubMed ID: 15139090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of glaucoma medications.
    Fiscella RG; Jensen MK
    Am J Ophthalmol; 2008 Jun; 145(6):1108-9; author reply 1109. PubMed ID: 18503789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome beyond blood pressure control?
    Staessen JA; Wang JG; Birkenhäger WH
    Eur Heart J; 2003 Mar; 24(6):504-14. PubMed ID: 12643883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Should we assess the cost of a drug before prescribing it?].
    Giner Valero M; Feliu Sagalá M; López Martínez A; Gracia Romero L
    Aten Primaria; 1996 Feb; 17(3):233-4. PubMed ID: 8664439
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescribing herbal medications appropriately.
    Ernst E
    J Fam Pract; 2004 Dec; 53(12):985-8. PubMed ID: 15581442
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rational prescribing and cost reduction in the treatment of arterial hypertension: a simulation exercise].
    Bonet A; Gosalbes V; Fito M; Navarro J
    Gac Sanit; 2001; 15(4):327-35. PubMed ID: 11578562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is patients' insurance coverage associated with prescribing after hospitalization for severe, poorly controlled hypertension?
    Dy SM; Klag MJ; Young JH
    J Clin Hypertens (Greenwich); 2008 Sep; 10(9):684-91. PubMed ID: 18844763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decisions by the state, county council's money and my patient. Consequences of the LFN survey of antihypertensive agents].
    André M; Andersén-Karlsson E; Landahl S; Löfmark R; Silfverhielm B; Skoglund I
    Lakartidningen; 2008 May 21-27; 105(21):1549-50. PubMed ID: 18574990
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis.
    Fretheim A; Aaserud M; Oxman AD
    BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.
    Siegel D; Lopez J
    JAMA; 1997 Dec; 278(21):1745-8. PubMed ID: 9388150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
    Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
    Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduce prescription of expensive drugs without increased value].
    Furberg C
    Lakartidningen; 2003 Dec; 100(49):4113. PubMed ID: 14717079
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug information--national decision needed].
    Ohman U; Nilsson A
    Lakartidningen; 2008 Jul 9-22; 105(28-29):2038. PubMed ID: 18711826
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hypertension at a health center. 1: The drugs prescribed for men are much more expensive than the ones prescribed for women].
    Johannesson M; Borgquist L; Elenstål A; Jönsson B; Tilling B
    Lakartidningen; 1991 Mar; 88(12):1096-8. PubMed ID: 2016944
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.
    Chapman RH; Ferrufino CP; Kowal SL; Classi P; Roberts CS
    Int J Clin Pract; 2010 Jan; 64(2):169-81. PubMed ID: 20089007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.